Cloning and expression of neurocan, a chondroitin sulfate proteoglycan
US5648465A · kind A · utility
16Cited by
1References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 14, 1994 |
| Grant date | Jul 15, 1997 |
| Priority date | — |
| Expiry date | Nov 14, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Novel eukaryotic neurocan polypeptides, derivatives and analogs thereof and nucleic acid encoding therefor, which are useful for providing soluble, biologically active heterologous proteins in hosts, as well as hosts transformed with this nucleic acid and methods for producing soluble heterologous proteins in hosts using such molecules, and therapeutic uses thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.